维普期刊资源整合服务平台（V6.5）

97篇 您的检索式：作者名="BOLTZE C"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	p16INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas显示文摘	Semczuk A Boltze C Marzec B	2003	J Cancer Res Clin Oncol2003，129，10：	1
2	Intra muscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice显示文摘	Boltz D A Ilyushina N A Arnold C S	2008	Antiviral Res2008，80，2：	1
3	Skull base and nonskull base chordomas:Clinicopathologic and immunohistochemical study with special reference to nuclear pleomorphism and proliferative ability显示文摘	Naka T Boltze C Samii A	2003	Cancer2003，98，9：	1
4	Loss of maspin is a helpful prognosticator in colorec- tal cancer: a tissue microarray analysis 显示文摘	Boltze C	2005	Pathol Res Pratt2005，200，1112：	1
5	Genetic and epigenetic alterations in tumor progression in a dedifferentiated chondrosarcoma显示文摘	Ropke M Boltze C Neumann HW	2003	Pathol Res Pract2003，199，6：	1
6	Loss of p16 protein de- fines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study显示文摘	Schneider-Stock R Boltze C Lasota J	2005	Clin Cancer Res2005，11，21：	1
7	Loss of maspin is a helpful prognosticator in colorectal cancer : a tissue microarray analysis显示文摘	Boltze C	2005	Pathol Res Pract2005，200，：	1
8	Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues 显示文摘	Steinert M Wobus M Boltze C	2002	Am J Pathol2002，161，5：	1
9	Expression of matrix metalloproteinase (MMP)-1,MMP-2,MMP-9,cathepsin B,and urokinase plasminogen activator in non-skull base chordoma显示文摘	Naka T Boltze C Kuester D	2004	Am J Clin Pathol2004，122，6：	1
10	Loss of p16 protein de- fines high-risk patients with gastrointestinal stromal tumors: a tissue mieroarray study显示文摘	Schneider-Stock R Boltze C Lasota J	2005	Clin Cancer Res2005，11，2：	1
11	Expression of hepatocytegrowth factor and c-MET in skull base chordoma 显示文摘	Naka T Kuester D Boltze C	2008	Cancer2008，112，1：	1
12	Homozygous proline at codon 72 of p53 as a potential risk factor favoring the development of undifferentiated thyroid carcinoma显示文摘	Boltze C Roessner A Landt O	2002	Int J Oncol2002，21，5：	1
13	Hypermethylation of the CD-KN2 /p16 INK4A promotor in thyroid carcinogenesis 显示文摘	BOLTZE C ZACK S QUEDNOW C	2003	Pathol Res Pract2003，199，：	1
14	CD97,CD95 and Fas-L clearly discriminate between chronic pancreatitis and pancreatic ductal adenocarcinoma in perioperative evaluation of cryocut sections 显示文摘	Boltze C Schneider-Stock R Aust G	2002	Pathol Int2002，52，2：	1
15	A comparison of three techniques to determine the nonlinearity ultrasonic parameter显示文摘	Hurley D C Yost W T Boltz E S		0，，：	1
16	Maspin in thyroid cancer:its relationship with p53 and clinical outcome 显示文摘	Boltze C Schneider-Stock R Meyer F	2003	Oncol Rep2003，10，6：	1
17	Loss of Masp in is a helpful prognosticator in color- ectal cancer a tissuemicroarray analysis 显示文摘	Boltze C	2005	Pathol Res Pract2005，200，1112：	1
18	Elevated telomerase activity, c-myc, and hTERT mRNAexpression: association with tumour progression in malignant lipomatous tumours 显示文摘	Schneider-Stock R Boltze C Jager V	2003	J Pathol2003，199，：	1
19	Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells viaa p53-dependent mechanism显示文摘	D iab-Assdf M Boltze C	2004	Int J Oncol2004，25，4：	1
20	Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells viaa p53 dependent mechanism显示文摘	Gali Muhtasib H Diab Assdf M Boltze C	2004	Int J Oncol2004，25，4：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示